1. Home
  2. IMTX vs BVS Comparison

IMTX vs BVS Comparison

Compare IMTX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immatics N.V.

IMTX

Immatics N.V.

SELL

Current Price

$6.21

Market Cap

992.8M

Sector

Health Care

ML Signal

SELL

Logo Bioventus Inc.

BVS

Bioventus Inc.

SELL

Current Price

$10.43

Market Cap

910.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IMTX
BVS
Founded
N/A
2011
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
992.8M
910.2M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
IMTX
BVS
Price
$6.21
$10.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$15.97
★ $16.60
AVG Volume (30 Days)
★ 1.0M
611.2K
Earning Date
11-10-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 163.46
EPS
N/A
★ 0.60
Revenue
N/A
★ $568,087,000.00
Revenue This Year
N/A
$4.72
Revenue Next Year
$14.22
$6.41
P/E Ratio
★ N/A
$17.46
Revenue Growth
★ N/A
N/A
52 Week Low
$6.07
$6.47
52 Week High
$12.41
$15.89

Technical Indicators

Market Signals
Indicator
IMTX
BVS
Relative Strength Index (RSI) 33.37 31.09
Support Level N/A $9.82
Resistance Level $7.95 $11.00
Average True Range (ATR) 0.46 0.68
MACD -0.02 -0.22
Stochastic Oscillator 8.26 6.50

Price Performance

Historical Comparison
IMTX
BVS

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: